One of the clearest signs that healthcare is changing—quietly, but relentlessly—is when respected clinicians start treating AI not as a novelty, but as a skill clinicians must learn, like interpreting a chest X-ray or running a code. Personally, I think the appointment of Hassan Bencheqroun to an editorial board is less about a single person and more about the direction the whole industry is inevitably moving: toward “clinical AI literacy” as a professional baseline, not an optional hobby.
What makes this particularly fascinating is that Dr. Bencheqroun’s background sits right in the pressure zone where medicine meets real-world constraints—critical care, education, research, and technology. From my perspective, that combination matters because AI in healthcare doesn’t fail primarily in academic demonstrations; it fails at the bedside, in workflows, in the handoffs between teams, and under the time pressure that defines critical care.
And that’s where an editorial role can become more than ceremonial. In my opinion, the editorial board seat is a strategic lever: it shapes what gets published, what gets emphasized, and—most importantly—what gets normalized as “safe and practical.”
Why AI literacy is becoming a clinical responsibility
If you take a step back and think about it, “AI literacy” in medicine isn’t the same thing as knowing how a chatbot works. Personally, I think people underestimate how specific the literacy needs to be: clinicians must understand where a model is strong, where it’s likely to hallucinate or underperform, what kinds of data it learned from, and how that translates into decisions made under uncertainty.
One thing that immediately stands out is the way Dr. Bencheqroun is described as working on “practical, safe, and meaningful” AI adoption. What many people don’t realize is that “meaningful” often conflicts with “technically impressive.” A model can look great in a paper and still be a poor fit for how clinicians actually practice—especially during emergencies when distractions, interruptions, and incomplete information are the rule, not the exception.
Personally, I suspect the biggest misunderstanding is treating AI education like a generic “digital health” workshop. In my view, what healthcare needs is scenario-based learning tied to clinical consequences: how to question a result, how to validate it, and when to disregard it.
This raises a deeper question: who should bear the burden of understanding AI—the people building it, or the people responsible for acting on it? Editorial leadership matters here, because it influences whether the field encourages transparent evidence and clinical usability, or whether it rewards marketing-like research without enough bedside accountability.
Critical care is the toughest proving ground
Critical care isn’t just another specialty; it’s the stress test of any intervention. From my perspective, that’s why Dr. Bencheqroun’s identity as a board-certified critical care physician feels relevant. In the ICU, the margin for error is thin, and the consequences of a wrong turn can be immediate.
What this really suggests is that if someone is thinking about AI adoption in critical care, they’re likely being forced to confront the hard questions early: model reliability over time, performance across patient subgroups, and the way AI outputs integrate—or fail to integrate—into existing clinical thinking.
Here’s the opinionated part: healthcare often talks about “safety” as if it’s a checkbox, but safety in AI is closer to an ongoing relationship. I think we should expect continuous monitoring, human oversight that isn’t performative, and clear responsibility when systems behave unexpectedly.
From my perspective, that mindset is exactly what editorial boards should help cultivate. If the literature and commentary trend toward realistic deployment constraints, clinicians can learn to treat AI as an assistive tool with boundaries—not an oracle.
Industry, academia, and Tele-ICU: a rare workflow perspective
Dr. Bencheqroun is described with affiliations spanning education, a senior role at IQVIA, and association with Tele-ICU leadership. Personally, I see a pattern: the more roles someone has across the “from data to bedside” pipeline, the less likely they are to fall for simplistic narratives about AI.
In my opinion, Tele-ICU and similar models reveal a brutal truth about healthcare technology: it lives or dies by workflow. You can have a sophisticated AI system, but if it creates extra steps, slows decision-making, or introduces ambiguity, clinicians will stop trusting it—or stop using it.
A detail that I find especially interesting is that he’s positioned to help “fellow clinicians navigate and adopt AI.” That wording signals something important: adoption is not training alone; it’s cultural change. Clinicians need reassurance that AI won’t undermine clinical judgment, and administrators need evidence that AI won’t create hidden operational chaos.
If you connect this to a broader trend, you can see why editorial oversight matters now. The publishing ecosystem often rewards novelty; the real world rewards usability, measurable outcomes, and fewer unintended consequences.
Education platforms and podcasts aren’t fluff—they’re infrastructure
Founding an educational platform and hosting a podcast might sound like a marketing move to some people. Personally, I think it’s closer to building infrastructure for a new kind of literacy.
What many people don’t realize is that clinicians learn best through repetition and context, not through one-time conferences. When AI education is delivered through ongoing channels—courses, conversations, and practical examples—it becomes something people can revisit as tools evolve.
From my perspective, the “AI-Ready Doctor” concept is quietly radical because it reframes AI readiness as professional identity. That means people can discuss AI openly without fear of being “left behind,” and they can move from passive consumption to active critical evaluation.
This raises a deeper question: will healthcare treat AI literacy like continuing medical education, or like optional self-improvement? I suspect the field will eventually drift toward the first option, because the legal, ethical, and operational stakes are too high to leave it vague.
What editorial boards should demand in the AI era
If I’m being honest, I worry that the current AI publishing cycle sometimes rewards confident tone over clinical rigor. Personally, I want more emphasis on questions that matter to real humans: How did the model behave with incomplete data? What happens when it encounters edge cases? How often do clinicians override it, and why?
An editorial board can push the culture by prioritizing manuscripts that show implementation details, not just performance metrics. What this really suggests is a shift away from “accuracy at one moment” toward “safety across time,” including drift, changing patient populations, and evolving documentation practices.
Here are a few areas I’d expect more consistently in AI-related submissions as clinicians become more central stakeholders:
- Transparent validation methods (including how bias and subgroup performance were assessed)
- Usability and workflow evaluation (how clinicians actually interact with the system)
- Clear accountability language (what clinicians must verify, and what systems guarantee)
- Post-deployment monitoring plans (how performance changes will be detected)
In my opinion, the most important editorial contribution will be insisting that AI research respects clinical uncertainty. Medicine is not a static test set, and models should not pretend otherwise.
The deeper implication: medicine is becoming a team sport with machines
One broader trend stands out to me: healthcare is gradually transforming from “doctor knows best” into “team coordinates decisions,” where machines play a role in that coordination. Personally, I think this is neither inherently good nor bad—it’s just reality—but the ethical handling of that reality will determine whether AI improves care or erodes trust.
What this appointment signals, to me, is an intent to cultivate a more grounded, clinician-led approach to AI. Instead of waiting for vendors to define the terms, clinicians and educators can help define the boundaries of safe use.
From my perspective, the future of AI in medicine will belong to systems that can earn trust repeatedly—through transparency, predictable behavior, and respect for clinical judgment. That trust won’t be built by slogans; it will be built by education, evidence, and the kind of editorial gatekeeping that favors practical wisdom over hype.
The takeaway I’m left with is simple: AI literacy is becoming a core competency in healthcare, and editorial leadership is one of the levers that can accelerate responsible adoption. Personally, I hope more boards treat this as a mission, not a trend—and I think Dr. Bencheqroun’s profile is designed for exactly that kind of mission.
Would you like this article to lean more optimistic or more critical in tone?
